Nuventra Pharma Sciences is now Allucent. Learn more here.

Take a deeper dive


Webinar | Clinical Pharmacology 101: How to Form a Clinical Pharmacology Strategy for Your NDA or BLA

This event has passed. See all of our upcoming events, browse our Webinar Library for past presentations or, check out our Resource Library for blogs, case studies, news, toolkits and more. 

Join us on August 24th from 1:00pm – 2:00pm ET for a webinar titled, “Clinical Pharmacology 101: How to Form a Clinical Pharmacology Strategy for Your NDA or BLA.” Nuventra’s founder, Geoffrey Banks, Ph.D., will lead the session.

All drug or biologic programs must address clinical pharmacology to enable an approvable NDA or BLA. Understanding basic clinical pharmacology strategies such as which investigations you need or don’t need and which investigations to do now versus later is important for your program’s overall strategy. Join us to learn more about developing a clinical pharmacology strategy for your NDA or BLA.

At the end of this webinar, attendees should have a better understanding of:

  • Approaches to designing a clinical pharmacology program
  • How to build a clinical pharmacology program
  • Common mistakes and lessons learned
  • Hypothetical examples of clinical pharmacology program

This event is free of charge.

Meet the Presenter

Geoffrey Banks, Ph.D.

Geoffrey Banks, Ph.D., founded Nuventra in 2008 and led the company as both its CEO and as a principal consultant for more than 13 years prior to the Acquisition of Nuventra by CATO SMS. Dr. Banks has over 20 years of extensive experience in large pharma, biotechnology, and specialty pharma and an established track record of clinical, regulatory, and entrepreneurial success within the pharmaceutical industry.